Document is current
Any future updates will be listed below
-
Authors
Fedr, Radek
Kahounová, Zuzana
Remšík, Ján
Reiterová, Michaela
Kalina, Tomáš
Souček, Karel
-
Funding
Funding for this research was provided by:
American Brain Tumor Association
MSKCC Support Grant (P30 CA008748)
Ministerstvo Zdravotnictví Ceské Republiky (NU20J-07-00028, 18-08-00245, 18-08-00245)
European Union – Next Generation EU , National Institute for Cancer Research (LX22NPO5102, LX22NPO5102, LX22NPO5102)
Grantová Agentura České Republiky (20-22984S)
Ministerstvo Školství, Mládeže a Tělovýchovy („Preclinical Progression of New Organic Compounds with Targeted Biological Activity” (Preclinprogress) - CZ.02.1.01/0.0/0.0/16_025/0007381)
- License Information
-
More Information
Article History
Received: 7 June 2022
Accepted: 21 March 2023
First Online: 25 March 2023
Competing interests
: The authors declare no competing interests.
